By Rose Krebs ( July 12, 2022, 4:54 PM EDT) -- A stockholder has objected to another investor's bid for $850,000 in attorney fees in connection with a proposed settlement to end a derivative suit in Delaware Chancery Court over an allegedly unfair private offering that raised $70 million for Selecta Biosciences, arguing that his counsel should also get fees....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.